Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Sunway Healthcare targets $4.34b market cap with Malaysia IPO 2. 2026 biotech playbook: Hong Kong at the centre of China’s globalisation 3. IHH Healthcare FY2025 net profit falls 21% to $682.67m 4. Rising demand for advanced surgical devices to push market to $27.4b by 2032 5. Cardiac monitoring devices market to hit $37.88b by 2031Resource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation